1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024UCHL1 Overexpression Is Related to the Aggressive Phenotype of Non-small Cell Lung Cancer TUBERCULOSIS AND RESPIRATORY DISEASES
2024Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation EXPERIMENTAL AND MOLECULAR MEDICINE
2024RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer FRONTIERS IN ONCOLOGY
2024Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix: NEUROD1 as a Poor Prognostic FactorAMERICAN JOURNAL OF SURGICAL PATHOLOGY
2024Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatmentGYNECOLOGIC ONCOLOGY
2024Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer SCIENTIFIC REPORTS
2024Optimal Positioning of Load-Distributing Band CPR Device by Body Mass Index JOURNAL OF CLINICAL MEDICINE
2024Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer NATURE COMMUNICATIONS
2024Exploring the Potential of Enhanced Prognostic Performance of NCCN-IPI in Diffuse Large B-Cell Lymphoma by Integrating Tumor Microenvironment Markers: Stromal FOXC1 and Tumor pERK1/2 Expression CANCER MEDICINE
2024Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysisHISTOPATHOLOGY
2024Restoring H&E stain in faded slides via phase-to-color virtual staining in near-infrared APL PHOTONICS
2024Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13) CANCER RESEARCH AND TREATMENT
2024Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade CANCERS
2024A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaCLINICAL CANCER RESEARCH
2024Expression of PD-L1 in breast invasive lobular carcinoma PLOS ONE
2024Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers CANCER IMMUNOLOGY IMMUNOTHERAPY
2024Prediction of Bone Marrow Metastases Using Computed Tomography (CT) Radiomics in Patients with Gastric Cancer: Uncovering Invisible Metastases DIAGNOSTICS
2024Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment KOREAN JOURNAL OF RADIOLOGY
2024Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification SCIENTIFIC REPORTS
2024Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response COMMUNICATIONS BIOLOGY

Recent Submissions

Browse

Links